The ERICCIN trial is intended to investigate whether RIC, a simple non-invasive and low-cost intervention, can significantly reduce the rate of CIN in patients undergoing elective and semi-emergent coronary angiographic procedures, and whether improvement in biochemical markers are related to a persisting benefit in terms of renal function measured after 3 months of follow-up.
Although some authors have reported mild to moderate short-term symptomatic improvement with ESI, long-term follow-up studies have not demonstrated a persisting benefit (Arden et al. 2005; Koes et al. 1995; Wilson-MacDonald et al. 2005).
Importantly, a priori efficacy outcomes variables revealed a decrease of ∼50% in CHFS, Raynaud's severity and hand pain at 2 months with persisting benefits at 6 months.
Evidence for a cumulative association between LTPA across adulthood and lower fat mass (in women) and higher lean mass (in both sexes) supports the promotion of activity across adulthood on the basis of persisting benefits.
However, the lack of IDE induction with chronic UE2316 administration, in the face of persisting benefits for cognitive function, suggests that other pathways are involved in cognitive protection with 11β-HSD1 inhibition.
We hypothesized that early commencement of metformin and its continuation throughout puberty might have more persisting benefits.
Despite persisting clinical benefits, an increase in total direct cost for HIV pts has been seen for the first time during the HAART era in the year 2000, probably due to an over-prescription of HAART, according to actual Guideline for antiretroviral therapy use, to pts who were not at risk of clinical progression in the short term.
In animal models and patients, continuous aortic flow augmentation using the Orqis Medical Cancion System Orqis Medical Corporationn, Lake Forest, California), a percutaneously placed arterial-to-arterial circuit (continuous flow up to 1.5 L/min) with an extracorporeal, magnetic, centrifugal pump, improves hemodynamics and renal function with benefits persisting 24 hours after discontinuation.
It has been shown to improve vision with benefits persisting up to five years.
Overall, lorcaserin appears to be more effective than placebo in achieving a >5% weight loss over 52 weeks, with benefits persisting for an additional 52 weeks.
In contrast, the principles of optimised perioperative care have shown reduced penetrance in AUS/NZ with persisting scepticism regarding benefits [ 32, 33].
